Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03793569 · ClinicalTrials.gov registry record · NA
Does Enhancing Maternal Peer Interactions Decrease Rates of Postpartum Depression?
A NA study of Postpartum Depression, sponsored by Milton S. Hershey Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 33
- Enrollment target
- 1
- Study location
NCT03793569: Completed NA study of Postpartum Depression, sponsored by Milton S. Hershey Medical Center.
NCT03793569 is a NA study of Postpartum Depression that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 33 participants, below the 475-participant average among 47 other Postpartum Depression trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03793569, a NA study of Postpartum Depression, has completed, sponsored by Milton S. Hershey Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 33 participants
- Enrollment target
- 1
- Study location
Study Summary
The long-term goal of this study is to validate a simple and inexpensive intervention to reduce the incidence and impact of Postpartum Depression (PPD). The central hypothesis is that enhancing social support of new mothers specifically via an organized peer get-together will decrease rates of postpartum depression. The rationale for the proposed research is that even though PPD is common and risk factors for developing PPD are known, simple and inexpensive interventions to prevent PPD need to be studied. Postpartum mothers will be recruited for the study and randomized into control versus intervention group. The intervention group will be placed in a peer discussion group. Incidence of PPD will be tracked.
Primary Outcome
Edinburg Postnatal Depression Scale. Score 0-30. Score \> or = 10 considered greater risk of depression.
Conditions Studied
Interventions
- BEHAVIORAL Peer discussion group
Study Locations (1)
Pennsylvania
- Penn State Hershey Medical Center - Hershey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2018-08-27 |
| Est. Completion | 2019-07-30 |
| Phase | NA |
What the finished NCT03793569 record still lists
NCT03793569 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 33 participants, a relatively small participant target, below the 475-participant average among 47 other Postpartum Depression trials with a reported enrollment target (93% lower).
The record links to 1 condition, with Postpartum Depression appearing as the primary indexed condition, and to 1 intervention - of which Peer discussion group is the first listed.
NCT03793569 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT03793569 about?
NCT03793569 is a clinical study titled "Does Enhancing Maternal Peer Interactions Decrease Rates of Postpartum Depression?". The long-term goal of this study is to validate a simple and inexpensive intervention to reduce the incidence and impact of Postpartum Depression (PPD). The central hypothesis is that enhancing social support of new mothers specifically via an organized peer get-together will decrease rates of postp...
What is the current status of trial NCT03793569?
This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2018-08-27. Estimated completion is 2019-07-30.
What conditions does trial NCT03793569 study?
This clinical trial studies the following conditions: Postpartum Depression.
What interventions are being tested in trial NCT03793569?
The interventions under investigation include: Peer discussion group (BEHAVIORAL).
Who is sponsoring clinical trial NCT03793569?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03793569 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Postpartum Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03793569's enrollment target sits among peer trials
33 43rd of 47 higher than 5 of 47 other Postpartum Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Postpartum Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Preventing Postpartum Depression in Immigrant Latinas
RECRUITING · NA
-
In-person vs. Virtual Delivery of a Group-based Prevention of Postpartum Depression
RECRUITING · NA
-
Postpartum Care in the NICU (PeliCaN) Transitions
RECRUITING · NA
-
Maternal Mental Health Access - MaMa
RECRUITING · NA
-
The Mom and Infant Outcomes (MOMI) Study
RECRUITING · NA
-
Maternal Stress on Human Milk and Infant Outcomes
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02861898 · 33 participants · Phase 1
Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
- NCT04871607 · 33 participants · Phase 2
Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma
- NCT05071937 · 33 participants · Phase 2
ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer
- NCT05168618 · 33 participants · Phase 2
Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer, The AtezoCab Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI